News
Created in 2022 and based in Marseille, Ana Healthcare's mission is to accelerate medical research by simplifying the analysis of medical imaging data.
Created in Toulouse in 2017, Sêmeia develops simple, intuitive and effective support solutions for patients suffering from serious or chronic illnesses.
A specialist in respiratory diseases, the RespirERA university hospital institute (IHU), based in Nice, wants to prevent the ailments that atmospheric pollution and climate change will transform into a major public health problem tomorrow.
Inhibit cell death to save the myocardium and...
Created in 2013 and based in Grabels (34) and Labège (31), ...
The Max Delbrück Center, Berlin, and the biotech company AlgenScribe from France have agreed to cooperate to further develop their gene-editing tools. The aim is to utilize synergies, accelerate research, and ultimately develop cell therapies for genetically determined diseases.
Created in Toulouse in 2005, ABIONYX Pharma is a ...
Eurobiomed partner of the #CRIBS project led by the Montpellier University Hospital
Au sein du CERIMED, situé sur le site de la faculté de médecine de Marseille, les membres de l'équipe ont mené des tests d'efficacité du produit.
Cilcare, a pioneering biotechnology company in hearing sciences and the development of new therapies for hearing disorders and associated diseases, has the great pleasure of sending you its latest press release announcing the signing of an exclusive license option agreement with Shionogi.
La société Rofim, adhérente d'Eurobiomed, fait parti des 3 start-up française à intégrer le programme "Google for Startups".
Eurobiomed is pleased to welcome you on June 19 and 20, 2024, in Aix-en-Provence, for two absolutely unmissable events.